Application of fragment screening and merging to the discovery of inhibitors of the Mycobacterium tuberculosis cytochrome P450 CYP121

Sean A. Hudson, Kirsty J. McLean, S. Surade, Yong-Qing Yang, David Leys, Alessio Ciulli, Andrew W. Munro, C. Abell

    Research output: Contribution to journalArticle

    37 Citations (Scopus)

    Abstract

    Pieces of the puzzle: The first fragment-based approach was used to target cytochrome P450 enzymes (CYPs) for drug development (see scheme). The experiments provide new insights into the binding site of the essential Mycobacterium tuberculosis CYP121 enzyme, and resulted in a promising novel lead compound based on fragment merging.
    Original languageEnglish
    Pages (from-to)9311-9316
    Number of pages6
    JournalAngewandte Chemie International Edition
    Volume51
    Issue number37
    DOIs
    Publication statusPublished - 10 Sep 2012

    Fingerprint Dive into the research topics of 'Application of fragment screening and merging to the discovery of inhibitors of the <em>Mycobacterium tuberculosis</em> cytochrome P450 CYP121'. Together they form a unique fingerprint.

  • Cite this